Weiqiang Zhao

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Medicine, Hematology, Oncology +12

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.3K citations

Medicine, Oncology, Radiation Oncology +6

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 952 citations · Full text

Medicine, Immunology, Oncology +10

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer

Rachel Pearlman, Wendy L. Frankel, Benjamin Swanson et al. · JAMA Oncology · 2016 · 723 citations · Full text

Life Sciences, Genetics, Oncology +17

Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib

John C. Byrd, Richard R. Furman, Steven Coutré et al. · Blood · 2015 · 656 citations

Medicine, Pharmacology, Pharmacotherapy +8